Hi Kev
IMU will be updating on HER-Vaxx in due course. I would expect that when they do it will include even more 'up-to-date'
info on survival rates.
It is certainly not for lack of publishing on their part. See below for what is coming. IMU is one of the busiest bio-techs on
the ASX, in fact, the list below is mind-blowing IMO. So much in the pipeline. 2022 may not have excited everybody, but 2023
looks like being 'one out of the box'.
All in my opinion and certainly not financial advice.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.1¢ | $170.5K | 14.18M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 63 | 15101653 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10785516 | 25 |
View Market Depth
| Last trade - 13.13pm 25/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |